pISSN 1226-6051
eISSN 2508-786X

Fig. 3.

Download original image
Fig. 3.

Treatment responses in therapeutic drug monitoring (TDM) vs. non-TDM groups at 2, 6, 12 weeks, and the end of voriconazole administration. Data are No. (%). From the Chi-square test or Fisher’s exact test. aPatients who completed voriconazole within 6 weeks were excluded from the analysis; 2 patients in TDM group, 8 patients in non-TDM group. bPatients who completed voriconazole within 12 weeks were excluded from the analysis; 4 patients in TDM group, 14 patients in non-TDM group

Korean J Clin Pharm 2019;29:89-100 https://doi.org/10.24304/kjcp.2019.29.2.89
© 2019 Korean J Clin Pharm